Storm clouds around AI patentability
With the global technology race to create large scaled AI learning systems utilising Artificial Neural Networks (ANNs) and Reinforcement Learning, there has been a general reluctance of patent offices...
With the global technology race to create large scaled AI learning systems utilising Artificial Neural Networks (ANNs) and Reinforcement...
Read More
Landmark IP Decision by China Supreme Court
The Supreme Court of the P.R. China recently announced the decision of an appeal case involving a dispute over patents and technology secrets related to new energy vehicle chassis...
The Supreme Court of the P.R. China recently announced the decision of an appeal case involving a dispute over...
Read More
Sanofi v Amgen dispute: Australian update
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners around the world. The patent litigation concerning Amgen’s PCSK9 antibody...
It’s one of the most consequential pharmaceutical patent disputes in years, one that is being closely watched by practitioners...
Read More
Australia second in cleantech growth – tips for in-house counsel
With a landscape so compatible with cleantech solutions, no wonder Australia is a hotbed for innovation. We discuss this and provide tips for IP professionals working in the sector.
With a landscape so compatible with cleantech solutions, no wonder Australia is a hotbed for innovation. We discuss this...
Read More
Privacy Act legislation overhaul expected this month
A review of Australia’s Privacy Act 1988 (Cth) (Privacy Act) has been ongoing since 2020, and has produced 116 proposed reforms. The expected legislative changes will have implications for...
A review of Australia’s Privacy Act 1988 (Cth) (Privacy Act) has been ongoing since 2020, and has produced 116...
Read More
Spruson & Ferguson announces 21 promotions in 2024, including two Principals
Spruson & Ferguson is proud to announce a record 21 promotions across Australia and Asia, including two Principal appointments. Promotions have been made across a range of practice areas, in...
Spruson & Ferguson is proud to announce a record 21 promotions across Australia and Asia, including two Principal appointments. Promotions...
Read More
Skinny labelling in the Australian context: an overview
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be protected by several different patent claim formats, including method of...
This article was first published in the 2023 Pharmaceutical Patent Review. Key takeaways In Australia, new indications for known pharmaceuticals may be...
Read More
IAM Patent 1000 2024
Spruson & Ferguson has once again been recognised in the 2024 IAM Patent 1000 rankings across the Asia-Pacific, with an outstanding result in multiple countries. We are delighted to announce the...
Spruson & Ferguson has once again been recognised in the 2024 IAM Patent 1000 rankings across the Asia-Pacific, with an outstanding...
Read More
Pharmaceutical patent term extension in Australia
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial importance, and in recent years have become of particular interest...
This article was first published in the 2023 Pharmaceutical Patent Review. Patent term extensions (PTEs) can be of great commercial...
Read More

Contact our Expert Team

Contact Us
Contact Us